Fierz Ronja, Ghisu Gian-Piero, Fink Daniel
Department of Gynaecology, University Hospital Zurich, Zurich, Switzerland.
Case Rep Obstet Gynecol. 2019 Jan 16;2019:4820396. doi: 10.1155/2019/4820396. eCollection 2019.
Squamous cell carcinoma (SCC) of the neovagina after genital reconstruction surgery is a rare occurrence with only very few cases published up to the present. We report a case of a 43-year-old transgender woman who developed neovaginal SCC 23 years after vaginoplasty. The patient tested positive for high-risk human papillomavirus (HPV). At the time of diagnosis, radiological investigations revealed already existing lymph node and osseous metastases. The treatment consisted of various cycles of chemotherapy and radiation therapy. Unfortunately, the formation of additional metastases, including cerebral, pulmonary, and hepatic metastases, could not be prevented. After comparing the literature on the topic, we conclude that neovaginal carcinoma often appears years and decades after genital reconstruction surgery. We therefore recommend the continuation of regular clinical follow-up for transgender women after postoperative follow-up is completed. With this approach, potential lesions may be detected at an earlier stage and a better outcome may be achieved. Follow-up should include neovaginal examination and cytological smear testing. At a later age, we recommend additional regular prostate-specific antigen (PSA) testing and digital rectal examination (DRE). Moreover, transgender women are advised to take part in mammography screening starting at the age of 50, especially when additional risk factors are present.
生殖器重建手术后新阴道鳞状细胞癌(SCC)是一种罕见的情况,迄今为止仅有极少数病例报道。我们报告一例43岁的跨性别女性,在阴道成形术后23年发生了新阴道SCC。该患者高危人乳头瘤病毒(HPV)检测呈阳性。在诊断时,影像学检查显示已有淋巴结和骨转移。治疗包括多个周期的化疗和放疗。不幸的是,包括脑、肺和肝转移在内的额外转移无法预防。在比较了该主题的文献后,我们得出结论,新阴道癌通常在生殖器重建手术后数年甚至数十年出现。因此,我们建议在跨性别女性术后随访完成后继续进行定期临床随访。通过这种方法,潜在病变可能在更早阶段被检测到,从而可能获得更好的结果。随访应包括新阴道检查和细胞学涂片检测。在年龄较大时,我们建议额外定期进行前列腺特异性抗原(PSA)检测和直肠指检(DRE)。此外,建议跨性别女性从50岁开始参加乳腺钼靶筛查,尤其是存在其他风险因素时。